Medical Weight Loss for Quincy, Massachusetts Residents

Quincy, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Quincy through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Quincy, Massachusetts by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Quincy Residents Choose New Hope Weight Loss

Cost should not be a guessing game, and in Quincy it is not. Our flat pricing means semaglutide from $166 a month, tirzepatide from $233 a month, and a $119 physician review, with the medication billed separately and nothing buried in fine print. People across Massachusetts tell us the relief of simply knowing the number ahead of time is half the reason they finally got started.

If you are searching for medical weight loss in Quincy, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Quincy sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Massachusetts. We care for patients throughout Downtown, the waterfront, and the greater South Shore of metro Boston. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Quincy you are.

You can start this week from anywhere in Massachusetts, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. Between Klarna, Affirm, and HSA or FSA cards, Quincy patients have several ways to handle the $119 review and ongoing medication payments. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Quincy telehealth visits.

How Telehealth Works for Quincy

No waiting rooms, no commute across Quincy traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Quincy home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Quincy

I am searching for weight loss care near Quincy. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Quincy, Massachusetts connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Quincy?

Not at all. The telehealth format covers Quincy patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Quincy in cold-pack packaging built to keep it cool and stable.

What are the program costs for Quincy patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Quincy patients face no distance surcharge.

What areas of Quincy do you serve?

We serve patients from across Quincy by telehealth, including Downtown, the waterfront, and the greater South Shore of metro Boston.

What support is there for side effects for Quincy patients?

Dr. Sharma starts Quincy patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.

Quincy Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Quincy, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.